Meniere’s Disease Treatment Market Overview
The Meniere’s Disease Treatment Market is expected to reach USD 1351.67 Million by 2030 at 3.10% CAGR during the forecast period 2022-2030.
Meniere’s disease is a disorder of the inner ear that can lead to vertigo, tinnitus, and progressive deafness. The disease can develop at any age, but most commonly appears between the age of 40 to 60 years and normally affects only one ear. There is no cure for Meniere’s disease, but certain treatments can help reduce the severity and frequency of vertigo episodes.Factors such as the high prevalence rate of Meniere’s disease and government initiatives to create awareness regarding vestibular disorders in developed countries are driving the Meniere’s Disease Treatment Market Overview . However, factors such as lack of awareness in developing countries, and adverse side effects of symptomatic treatments are hampering the growth of the Meniere’s disease treatment market. A strong pipeline focusing on developing a specific treatment for Meniere’s disease serves as an opportunity for the growth of the Meniere’s disease treatment market.
get a free sample:https://www.marketresearchfuture.com/sample_request/3991
Segmentation
The high prevalence rate of Meniere’s disease is one of the key factors driving market growth. Meniere’s disease is caused by a dysfunction of the semi-circular canals in the ear and can lead to vertigo, tinnitus, and progressive deafness. The growing cases of Meniere’s disease are generating the demand for treatment, which attributes to the growth of the Meniere’s disease treatment market globally. According to the Hearing Health Foundation, there were around 600,000 to 750,000 cases of Meniere’s disease in the US as of 2018 and over 45,000 to 60,000 new cases are diagnosed annually.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/menieres-disease-market-3991
Key Players
MRFR recognizes the following companies as the Key Players in the Global Meniere’s Disease Treatment Market— Sound Pharmaceuticals (US), LiNA Medical ApS (Europe), Wallace Pharma (India), Jubilant Cadista(US), Pfizer Inc. (US), Glenmark Pharmaceuticals (India), GlaxoSmithKline PLC (UK), WellSpring Pharmaceutical Corporation (US), Auris Medical (Bermuda), Otonomy, Inc. (US) and others
Regional Analysis
The Americas accounted for the largest share in 2018 in global Meniere’s disease treatment market. This is owing to the increasing prevalence of Meniere’s Disease in the US and the rising number of market players focusing on Meniere’s disease-specific treatment. Moreover, manufacturers such as Otonomy and Sound Pharmaceuticals, with a presence in the US, are focusing on developing drugs specific to Meniere’s disease. For instance, OTIVIDEX, by Otonomy, Inc. is a sustained-exposure formulation of the steroid dexamethasone for patients with Meniere’s disease and has completed the Phase 3 clinical trial. This adds to the growth of Meniere’s disease in the Americas region.
Asia-Pacific is estimated to be the fastest-growing region in Meniere’s disease treatment market. The increasing prevalence of vestibular disorders in the region is blooming the growth of Meniere’s disease treatment market. A majority of companies in Asia-Pacific are committed to investing in research and development of advanced treatments, which will ultimately boost the growth of the market.
The market in the Middle East & Africa is likely to exhibit the lowest growth owing to the limited access and availability of treatment facilities. Moreover, limited developments in technology may slow the market growth rate in this region.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
